Please login to the form below

Not currently logged in
Email:
Password:

Drug prices

This page shows the latest Drug prices news and features for those working in and with pharma, biotech and healthcare.

Healthcare sector bullish, despite political uncertainty

Healthcare sector bullish, despite political uncertainty

transition. Across the Atlantic the big topic has been drug pricing, but despite the rhetoric coming out of the White House, most of the those polled (92%) do not think there ... Drug prices are expected to keep rising, but at a muted pace, ”says the

Latest news

  • Democrats regain control of House in mid-terms Democrats regain control of House in mid-terms

    limiting medicine prices in the US which have been giving industry some sleepless nights. ... That includes a plan to use a reference system based on other countries to set the prices of medicines in Medicare Part B – which left the industry aghast

  • US pricing plan slammed for imposing “foreign price controls” US pricing plan slammed for imposing “foreign price controls”

    It’s the latest in a series of new proposals in Trump’s war on drug prices, coming after plans to do away with the current rebate system for medicines to ... prevent ‘middlemen’taking a cut of a medicine’s price, and placing list prices in

  • Let's throw it against the wall and see what sticks... Let's throw it against the wall and see what sticks...

    The US administration states that this policy proposal is designed to lower drug prices. ... Consumers are already aware of the egregious nature of today’s drug prices.

  • US says medicine ads should include list prices US says medicine ads should include list prices

    US says medicine ads should include list prices. Hopes the proposal will encourage lower prescription drug prices. ... The US government has said pharma companies should disclose the list price of products in direct-to-consumer TV advertising, as part of

  • US insurers can peg access to ICER value reviews US insurers can peg access to ICER value reviews

    drug prices by pocketing rebates and not passing on savings to customers. ... While it is often lost in the debate over who is responsible for high drug prices, CVS Caremark has been able to help improve adherence and keep drug cost inflation under

More from news
Approximately 9 fully matching, plus 163 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Trump had tweeted days before that Pfizer “should be ashamed that they have raised drug prices for no reason”, claiming they were “taking advantage of the poor and others unable to ... The Trump administration has also just floated the idea of

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Quizzed about disagreements. over drug prices, Stevens played down the suggestion of an adversarial approach. ... While the drug is an undoubted breakthrough in the disease, NHS England says the company needs to lower its prices before it can allow

  • Health on instalment Health on instalment

    For example, the ophthalmic drug Luxturna, approved last year, costs $850, 000 per dose. ... In a company statement, even chief medical officer of pharmacy benefit manager Express Scripts Steve Miller, usually a fierce critic of high drug prices, offered

  • The rise of real-world evidence The rise of real-world evidence

    Notably, manufacturers and government and private payers are responding to concerns about drug prices by tying payments to outcomes. ... Spark Therapeutics has a similar arrangement for its gene therapy. These agreements make real-world efficacy a

  • US health reforms US health reforms

    In fact, it’s safe to say most C-suite drug executives would hardly shed a tear upon news of Obamacare’s swift demise. ... added. President Trump himself has frequently called for lower drug prices. “Once healthcare reform is done and Obamacare has

More from intelligence
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • A roadmap to strategic drug pricing

    A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. ... A roadmap to strategic drug pricing.

  • Oncology drugs under AMNOG

    Oncology drugs under AMNOG. Part 1: Segmentation and comparator choice - lessons for cancer drug market access in Germany. ... How to prepare. Germany is one of the largest pharmaceutical markets in Europe and drug prices there are used as reference

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics